Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vesico-Ureteral Reflux | 12 | 2021 | 427 | 2.710 |
Why?
|
Urinary Tract Infections | 8 | 2021 | 788 | 2.150 |
Why?
|
Hydronephrosis | 5 | 2023 | 269 | 2.070 |
Why?
|
Ureteral Obstruction | 8 | 2022 | 296 | 2.020 |
Why?
|
Glycomics | 3 | 2021 | 121 | 1.790 |
Why?
|
Tandem Mass Spectrometry | 8 | 2021 | 1157 | 1.400 |
Why?
|
Urine | 5 | 2020 | 370 | 1.240 |
Why?
|
Polysaccharides | 7 | 2021 | 1053 | 1.150 |
Why?
|
Proteomics | 10 | 2021 | 3638 | 1.110 |
Why?
|
Urinary Tract | 7 | 2019 | 309 | 1.080 |
Why?
|
Urologic Diseases | 5 | 2019 | 244 | 1.080 |
Why?
|
Nephrectomy | 5 | 2018 | 1050 | 1.050 |
Why?
|
Kidney | 13 | 2023 | 7186 | 1.030 |
Why?
|
Robotics | 7 | 2010 | 899 | 0.990 |
Why?
|
Glycoproteins | 5 | 2016 | 2263 | 0.930 |
Why?
|
Glycosylation | 6 | 2021 | 1126 | 0.870 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2022 | 68 | 0.850 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 58 | 0.850 |
Why?
|
Proteome | 3 | 2020 | 1799 | 0.840 |
Why?
|
Pelvic Neoplasms | 1 | 2023 | 254 | 0.760 |
Why?
|
Laparoscopy | 10 | 2018 | 2151 | 0.730 |
Why?
|
Rhabdomyosarcoma | 1 | 2023 | 382 | 0.710 |
Why?
|
Kidney Pelvis | 4 | 2022 | 188 | 0.660 |
Why?
|
Radionuclide Imaging | 3 | 2020 | 2031 | 0.640 |
Why?
|
Cryptorchidism | 2 | 2021 | 125 | 0.630 |
Why?
|
Urologic Surgical Procedures | 5 | 2018 | 302 | 0.620 |
Why?
|
Chromatography, Liquid | 6 | 2020 | 976 | 0.560 |
Why?
|
Adrenalectomy | 1 | 2018 | 341 | 0.540 |
Why?
|
Urography | 4 | 2019 | 313 | 0.530 |
Why?
|
Proteins | 4 | 2013 | 6103 | 0.500 |
Why?
|
Urothelium | 1 | 2017 | 277 | 0.500 |
Why?
|
Urinary Bladder | 2 | 2023 | 1172 | 0.490 |
Why?
|
Cicatrix | 2 | 2020 | 764 | 0.490 |
Why?
|
Ureter | 4 | 2015 | 375 | 0.470 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2014 | 177 | 0.460 |
Why?
|
Bladder Exstrophy | 2 | 2022 | 107 | 0.460 |
Why?
|
Wilms Tumor | 1 | 2016 | 373 | 0.460 |
Why?
|
Lymph Node Excision | 2 | 2018 | 1261 | 0.430 |
Why?
|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2012 | 26 | 0.430 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 503 | 0.420 |
Why?
|
Urogenital Abnormalities | 3 | 2019 | 261 | 0.380 |
Why?
|
Infant | 23 | 2021 | 35136 | 0.380 |
Why?
|
Microwaves | 1 | 2012 | 191 | 0.380 |
Why?
|
Urethral Stricture | 1 | 2010 | 51 | 0.370 |
Why?
|
Cystostomy | 2 | 2007 | 26 | 0.360 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2245 | 0.360 |
Why?
|
Child | 26 | 2023 | 77709 | 0.340 |
Why?
|
Child, Preschool | 22 | 2022 | 41006 | 0.340 |
Why?
|
Replantation | 1 | 2010 | 148 | 0.330 |
Why?
|
Ultrasonography | 7 | 2020 | 5985 | 0.320 |
Why?
|
Technetium Tc 99m Dimercaptosuccinic Acid | 3 | 2020 | 79 | 0.300 |
Why?
|
Immunoglobulin G | 3 | 2014 | 4560 | 0.300 |
Why?
|
Ureteral Diseases | 1 | 2007 | 61 | 0.300 |
Why?
|
Cloaca | 1 | 2006 | 52 | 0.290 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2007 | 85 | 0.280 |
Why?
|
Kidney Transplantation | 4 | 2007 | 4251 | 0.280 |
Why?
|
Body Burden | 1 | 2006 | 158 | 0.270 |
Why?
|
Male | 44 | 2023 | 350118 | 0.260 |
Why?
|
Protein Processing, Post-Translational | 2 | 2013 | 1990 | 0.260 |
Why?
|
Proteinuria | 1 | 2008 | 658 | 0.260 |
Why?
|
Humans | 70 | 2023 | 744343 | 0.250 |
Why?
|
Urethral Obstruction | 2 | 2019 | 56 | 0.240 |
Why?
|
Kidney Neoplasms | 2 | 2018 | 4262 | 0.240 |
Why?
|
Propylene Glycols | 1 | 2003 | 92 | 0.230 |
Why?
|
Carbohydrate Sequence | 2 | 2014 | 414 | 0.230 |
Why?
|
Cattle | 3 | 2014 | 3922 | 0.220 |
Why?
|
Radiation Protection | 1 | 2006 | 419 | 0.220 |
Why?
|
Safety Management | 1 | 2008 | 783 | 0.220 |
Why?
|
Kidney Calculi | 1 | 2007 | 465 | 0.220 |
Why?
|
Retroperitoneal Space | 2 | 2018 | 176 | 0.210 |
Why?
|
Testicular Neoplasms | 2 | 2021 | 804 | 0.210 |
Why?
|
Female | 37 | 2023 | 380194 | 0.210 |
Why?
|
Histocompatibility | 1 | 2003 | 330 | 0.210 |
Why?
|
Urethra | 2 | 2019 | 408 | 0.210 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2170 | 0.200 |
Why?
|
Blood Component Removal | 1 | 2002 | 125 | 0.200 |
Why?
|
Hernia, Umbilical | 1 | 2022 | 96 | 0.200 |
Why?
|
Renal Artery | 1 | 2003 | 398 | 0.200 |
Why?
|
Uromodulin | 1 | 2021 | 46 | 0.200 |
Why?
|
Feasibility Studies | 5 | 2020 | 5078 | 0.200 |
Why?
|
Fetal Diseases | 1 | 2006 | 903 | 0.190 |
Why?
|
Aneurysm, False | 1 | 2003 | 276 | 0.190 |
Why?
|
Creatinine | 3 | 2020 | 1919 | 0.190 |
Why?
|
Adolescent | 18 | 2022 | 85781 | 0.190 |
Why?
|
Molecular Sequence Annotation | 2 | 2013 | 528 | 0.180 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2020 | 68 | 0.180 |
Why?
|
Mannose | 1 | 2020 | 124 | 0.180 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2022 | 472 | 0.180 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2022 | 150 | 0.180 |
Why?
|
Fucose | 1 | 2020 | 125 | 0.180 |
Why?
|
Fever | 2 | 2021 | 1616 | 0.180 |
Why?
|
Abnormalities, Multiple | 2 | 2022 | 1416 | 0.170 |
Why?
|
Pelvic Pain | 2 | 2021 | 274 | 0.170 |
Why?
|
Radiation Injuries | 1 | 2006 | 1180 | 0.170 |
Why?
|
Recurrence | 3 | 2020 | 8340 | 0.170 |
Why?
|
Radiopharmaceuticals | 3 | 2020 | 2645 | 0.160 |
Why?
|
Retrospective Studies | 17 | 2022 | 77449 | 0.160 |
Why?
|
Contrast Media | 3 | 2020 | 5300 | 0.160 |
Why?
|
Catheterization, Central Venous | 1 | 2002 | 514 | 0.150 |
Why?
|
Cystectomy | 1 | 2023 | 686 | 0.150 |
Why?
|
Wounds, Nonpenetrating | 1 | 2003 | 794 | 0.150 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2019 | 257 | 0.150 |
Why?
|
Receptors, Nicotinic | 1 | 2019 | 497 | 0.140 |
Why?
|
Pedigree | 3 | 2019 | 4644 | 0.140 |
Why?
|
Receptor, EphA2 | 1 | 2016 | 42 | 0.140 |
Why?
|
Image Enhancement | 2 | 2020 | 2921 | 0.140 |
Why?
|
Cohort Studies | 6 | 2020 | 40561 | 0.130 |
Why?
|
Algorithms | 4 | 2023 | 13881 | 0.130 |
Why?
|
Sports | 1 | 2021 | 688 | 0.130 |
Why?
|
Endodermal Sinus Tumor | 1 | 2015 | 47 | 0.130 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2003 | 5442 | 0.130 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14722 | 0.130 |
Why?
|
Silicon Dioxide | 1 | 2016 | 213 | 0.130 |
Why?
|
Urination Disorders | 2 | 2009 | 241 | 0.130 |
Why?
|
Metabolome | 1 | 2021 | 895 | 0.120 |
Why?
|
Treatment Outcome | 13 | 2018 | 63114 | 0.120 |
Why?
|
Dogs | 6 | 2004 | 3912 | 0.120 |
Why?
|
Hematuria | 2 | 2007 | 235 | 0.120 |
Why?
|
Urinary Diversion | 2 | 2019 | 138 | 0.120 |
Why?
|
Molecular Sequence Data | 5 | 2015 | 18111 | 0.120 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2017 | 638 | 0.120 |
Why?
|
Renal Insufficiency | 1 | 2019 | 804 | 0.110 |
Why?
|
Spermatic Cord Torsion | 1 | 2013 | 73 | 0.110 |
Why?
|
Carbohydrate Conformation | 1 | 2013 | 208 | 0.110 |
Why?
|
Adult | 14 | 2022 | 214055 | 0.110 |
Why?
|
Hospitals, Pediatric | 2 | 2021 | 1775 | 0.110 |
Why?
|
T-Box Domain Proteins | 1 | 2015 | 471 | 0.110 |
Why?
|
Ribonucleases | 1 | 2013 | 287 | 0.110 |
Why?
|
Genes, Dominant | 1 | 2015 | 880 | 0.110 |
Why?
|
Animals | 19 | 2018 | 168757 | 0.110 |
Why?
|
Subcellular Fractions | 1 | 2013 | 547 | 0.110 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1681 | 0.100 |
Why?
|
Athletic Injuries | 1 | 2021 | 1154 | 0.100 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2012 | 154 | 0.100 |
Why?
|
Muscle, Smooth | 1 | 2015 | 934 | 0.100 |
Why?
|
Quality of Life | 2 | 2023 | 12804 | 0.100 |
Why?
|
Graft vs Host Disease | 1 | 2003 | 2957 | 0.100 |
Why?
|
Young Adult | 8 | 2022 | 56430 | 0.090 |
Why?
|
Molecular Weight | 1 | 2013 | 2255 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2003 | 4149 | 0.090 |
Why?
|
Catalysis | 1 | 2012 | 761 | 0.090 |
Why?
|
Brain Concussion | 1 | 2021 | 1320 | 0.090 |
Why?
|
Transplantation Chimera | 2 | 2003 | 612 | 0.090 |
Why?
|
Methods | 1 | 2010 | 1129 | 0.090 |
Why?
|
Mass Screening | 2 | 2020 | 5255 | 0.090 |
Why?
|
Syndrome | 3 | 2022 | 3251 | 0.090 |
Why?
|
Disease Susceptibility | 1 | 2017 | 1782 | 0.090 |
Why?
|
Infant, Newborn | 7 | 2020 | 25625 | 0.090 |
Why?
|
Length of Stay | 3 | 2008 | 6309 | 0.090 |
Why?
|
Blotting, Western | 1 | 2017 | 5179 | 0.080 |
Why?
|
Aging | 1 | 2008 | 8664 | 0.080 |
Why?
|
Biofeedback, Psychology | 1 | 2009 | 115 | 0.080 |
Why?
|
Chemical Precipitation | 1 | 2008 | 179 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 35421 | 0.080 |
Why?
|
Postoperative Complications | 4 | 2018 | 15295 | 0.080 |
Why?
|
Ultrafiltration | 1 | 2008 | 57 | 0.080 |
Why?
|
Fluorocarbons | 1 | 2013 | 452 | 0.080 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 279 | 0.080 |
Why?
|
Radiation Dosage | 3 | 2011 | 1928 | 0.080 |
Why?
|
Mutation | 3 | 2019 | 29786 | 0.080 |
Why?
|
Prognosis | 5 | 2019 | 29063 | 0.080 |
Why?
|
Urolithiasis | 1 | 2009 | 131 | 0.080 |
Why?
|
Freezing | 1 | 2008 | 303 | 0.080 |
Why?
|
Albumins | 1 | 2010 | 569 | 0.080 |
Why?
|
Prospective Studies | 4 | 2022 | 53288 | 0.080 |
Why?
|
Nomograms | 1 | 2009 | 228 | 0.080 |
Why?
|
Up-Regulation | 1 | 2017 | 4217 | 0.080 |
Why?
|
Peptides | 1 | 2020 | 4409 | 0.080 |
Why?
|
Urinalysis | 1 | 2009 | 369 | 0.070 |
Why?
|
Age Factors | 2 | 2018 | 18370 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8324 | 0.070 |
Why?
|
Orchiectomy | 2 | 2021 | 474 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3474 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3508 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2916 | 0.060 |
Why?
|
Suture Techniques | 2 | 2008 | 798 | 0.060 |
Why?
|
Urodynamics | 1 | 2006 | 347 | 0.060 |
Why?
|
Infant, Newborn, Diseases | 1 | 2010 | 582 | 0.060 |
Why?
|
Transplantation, Homologous | 5 | 2005 | 4776 | 0.060 |
Why?
|
Stents | 2 | 2007 | 3280 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9313 | 0.060 |
Why?
|
Risk Assessment | 3 | 2018 | 23338 | 0.060 |
Why?
|
Case Management | 1 | 2006 | 286 | 0.060 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2004 | 90 | 0.060 |
Why?
|
Fibronectins | 1 | 2008 | 726 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20129 | 0.060 |
Why?
|
Graft Survival | 3 | 2003 | 3737 | 0.060 |
Why?
|
Rats, Wistar | 1 | 2008 | 1901 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3617 | 0.060 |
Why?
|
Reproducibility of Results | 4 | 2020 | 19905 | 0.060 |
Why?
|
Protein Binding | 1 | 2016 | 9386 | 0.060 |
Why?
|
Appendix | 1 | 2004 | 110 | 0.060 |
Why?
|
Cadherins | 1 | 2008 | 907 | 0.060 |
Why?
|
Dystrophin | 1 | 2004 | 285 | 0.060 |
Why?
|
Operating Rooms | 1 | 2010 | 817 | 0.060 |
Why?
|
Isoantigens | 1 | 2005 | 567 | 0.050 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2004 | 906 | 0.050 |
Why?
|
Orchiopexy | 1 | 2021 | 20 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5391 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39050 | 0.050 |
Why?
|
Sphingosine | 1 | 2003 | 307 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2003 | 793 | 0.050 |
Why?
|
Congenital Abnormalities | 1 | 2006 | 707 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2011 | 1956 | 0.050 |
Why?
|
Radiation Tolerance | 1 | 2003 | 486 | 0.050 |
Why?
|
Graft Rejection | 2 | 2005 | 4397 | 0.050 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2005 | 1475 | 0.050 |
Why?
|
Kidney Function Tests | 1 | 2003 | 684 | 0.050 |
Why?
|
Reoperation | 2 | 2007 | 4201 | 0.050 |
Why?
|
Cyclosporine | 1 | 2003 | 786 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2013 | 5097 | 0.050 |
Why?
|
Genomic Imprinting | 1 | 2002 | 328 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4042 | 0.050 |
Why?
|
Middle Aged | 4 | 2020 | 213383 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3752 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2013 | 18029 | 0.040 |
Why?
|
Computer Simulation | 1 | 2013 | 6196 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16689 | 0.040 |
Why?
|
Mouth Mucosa | 1 | 2022 | 434 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2006 | 2203 | 0.040 |
Why?
|
Short Bowel Syndrome | 1 | 2002 | 345 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2002 | 11124 | 0.040 |
Why?
|
Software | 1 | 2013 | 4443 | 0.040 |
Why?
|
Quality Improvement | 1 | 2014 | 3749 | 0.040 |
Why?
|
Urinary Catheterization | 1 | 2019 | 202 | 0.040 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2022 | 336 | 0.040 |
Why?
|
Ultrasonography, Prenatal | 1 | 2006 | 1695 | 0.040 |
Why?
|
Transplantation Tolerance | 1 | 2003 | 617 | 0.040 |
Why?
|
Infant Care | 1 | 2019 | 183 | 0.040 |
Why?
|
Genes | 1 | 2002 | 1893 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 21827 | 0.040 |
Why?
|
CpG Islands | 1 | 2002 | 1172 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2006 | 21746 | 0.040 |
Why?
|
Pseudarthrosis | 1 | 1997 | 59 | 0.040 |
Why?
|
Tissue Donors | 2 | 2005 | 2240 | 0.040 |
Why?
|
Vagina | 1 | 2022 | 825 | 0.040 |
Why?
|
Motion | 1 | 2020 | 798 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17446 | 0.040 |
Why?
|
Rats | 2 | 2016 | 24260 | 0.040 |
Why?
|
Lung Transplantation | 1 | 2005 | 1153 | 0.040 |
Why?
|
Acute Disease | 2 | 2005 | 7149 | 0.040 |
Why?
|
Intestine, Small | 1 | 2002 | 1241 | 0.030 |
Why?
|
Sirolimus | 1 | 2003 | 1564 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2022 | 1236 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2003 | 2765 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2015 | 300 | 0.030 |
Why?
|
Time Factors | 4 | 2018 | 40075 | 0.030 |
Why?
|
Physician's Role | 1 | 2002 | 943 | 0.030 |
Why?
|
Risk | 1 | 2006 | 9687 | 0.030 |
Why?
|
Brachytherapy | 1 | 2002 | 1248 | 0.030 |
Why?
|
Athletes | 1 | 2021 | 1093 | 0.030 |
Why?
|
Bone Screws | 1 | 1997 | 520 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2297 | 0.030 |
Why?
|
Whole-Body Irradiation | 2 | 2004 | 449 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2593 | 0.030 |
Why?
|
Prostatectomy | 1 | 2002 | 1890 | 0.030 |
Why?
|
Base Sequence | 3 | 2015 | 12797 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2015 | 905 | 0.030 |
Why?
|
Eating | 1 | 2019 | 1536 | 0.030 |
Why?
|
Swine, Miniature | 2 | 2005 | 961 | 0.030 |
Why?
|
Artifacts | 1 | 2020 | 1904 | 0.030 |
Why?
|
Sequence Analysis, Protein | 1 | 2013 | 258 | 0.030 |
Why?
|
Patient-Centered Care | 1 | 2002 | 1439 | 0.020 |
Why?
|
Swine | 3 | 2008 | 5917 | 0.020 |
Why?
|
Pediatrics | 1 | 2006 | 3475 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1643 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 950 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 1997 | 975 | 0.020 |
Why?
|
Chronic Disease | 2 | 2021 | 9146 | 0.020 |
Why?
|
Radioisotope Renography | 1 | 2010 | 62 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2003 | 3110 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1770 | 0.020 |
Why?
|
Survival Analysis | 1 | 2003 | 10252 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3870 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16365 | 0.020 |
Why?
|
Joint Instability | 1 | 1997 | 792 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1915 | 0.020 |
Why?
|
Remission, Spontaneous | 1 | 2009 | 382 | 0.020 |
Why?
|
Survival Rate | 1 | 2003 | 12788 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2569 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2010 | 336 | 0.020 |
Why?
|
DNA Methylation | 1 | 2002 | 4286 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2699 | 0.020 |
Why?
|
Spinal Fusion | 1 | 1997 | 1241 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 1941 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3616 | 0.020 |
Why?
|
Urinary Bladder Diseases | 1 | 2008 | 166 | 0.020 |
Why?
|
Rabbits | 1 | 2013 | 4894 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15076 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 969 | 0.020 |
Why?
|
United States | 3 | 2021 | 69872 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3479 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2538 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 20947 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2010 | 924 | 0.020 |
Why?
|
Siblings | 1 | 2010 | 854 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4204 | 0.020 |
Why?
|
Electron Transport | 1 | 2006 | 211 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2006 | 361 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2003 | 15540 | 0.020 |
Why?
|
Leukocytes | 2 | 2004 | 2043 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2006 | 549 | 0.020 |
Why?
|
Aged | 1 | 2018 | 163280 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2010 | 1184 | 0.020 |
Why?
|
Electrons | 1 | 2006 | 268 | 0.020 |
Why?
|
Ileum | 1 | 2008 | 565 | 0.020 |
Why?
|
Acetylglucosamine | 1 | 2006 | 191 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 2004 | 4740 | 0.020 |
Why?
|
Mice | 4 | 2018 | 81183 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 1 | 2005 | 484 | 0.020 |
Why?
|
Lectins | 1 | 2006 | 513 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4803 | 0.010 |
Why?
|
Leukapheresis | 1 | 2003 | 131 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6756 | 0.010 |
Why?
|
Multifactorial Inheritance | 1 | 2010 | 1194 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13284 | 0.010 |
Why?
|
Histocompatibility Antigens | 1 | 2003 | 471 | 0.010 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2002 | 54 | 0.010 |
Why?
|
Liver Function Tests | 1 | 2003 | 528 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11366 | 0.010 |
Why?
|
Biomedical Research | 1 | 2017 | 3309 | 0.010 |
Why?
|
Chromosomes | 1 | 2004 | 596 | 0.010 |
Why?
|
Isoantibodies | 1 | 2005 | 679 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2004 | 13815 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2004 | 810 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5987 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2002 | 1085 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29144 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11031 | 0.010 |
Why?
|
Immunization | 1 | 2005 | 1256 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14557 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 3327 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 2839 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12959 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2005 | 1366 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2004 | 4320 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 72290 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2002 | 1202 | 0.010 |
Why?
|
Species Specificity | 1 | 2002 | 2478 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4751 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12245 | 0.010 |
Why?
|
Ilium | 1 | 1997 | 154 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2004 | 1620 | 0.010 |
Why?
|
Kinetics | 1 | 2003 | 6473 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3507 | 0.010 |
Why?
|
Databases, Factual | 1 | 2010 | 7729 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2002 | 2072 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6489 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7181 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1997 | 2124 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10943 | 0.010 |
Why?
|
Heart | 1 | 2003 | 4467 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 25043 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10481 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2004 | 4931 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10180 | 0.000 |
Why?
|
Lung | 1 | 2005 | 9856 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 12072 | 0.000 |
Why?
|
Transcription Factors | 1 | 2002 | 12208 | 0.000 |
Why?
|